Artikelnummer: GTX01555

SARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [CR3022], IgG1, Unconjugated, Human, Monoclonal

Bilder (0)

Produktbeschreibung

SARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [CR3022] binds to both SARS-CoV and SARS-CoV-2 with high affinity (PMID: 16796401 & 32065055). The initial characterization of the binding of this antibody was performed by ELISA and indicates potential for the development of diagnostic assays, as both virus-capture assays, or as controls in serological assays measuring immune responses to virus exposure. The original human IgG1 version of the antibody works synergistically in combination with another non-competing SARS antibody CR3014 and is a potential candidate for passive immune prophylaxis of SARS-CoV infection (ter Meulen et al., 2006). The original antibody (human IgG1) was also reported to bind the SARS-CoV-2 RBD (KD of 6.3 nM). This antibody may have potential as a therapeutic agent, alone or in combination with other neutralizing antibodies for treatment of SARS-CoV-2 infections (Tian et al., 2020).

* MwSt. und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten

Verfügbarkeit4 bis 7 Tage

Produktgarantie und Experten-Support

Artikelname:	SARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [CR3022], IgG1, Unconjugated, Human, Monoclonal
Artikelnummer:	GTX01555
Hersteller-Artikelnummer:	GTX01555
Alternativnummer:	GTX01555-100
Hersteller:	GeneTex
Wirt:	Human
Kategorie:	Antikörper
Anwendung:	ELISA, NeA
Spezies-Reaktivität:	Virus
Immunogen:	The original monoclonal antibody was generated by sequencing peripheral blood lymphocytes of a patient exposed to the SARS-CoV.
Konjugation:	Unconjugated
Alternative Namen:	2019-nCoV Spike, COVID-19 Spike, SARS-CoV-2 Spike, covid-19, sars-cov, sars-cov-2

Produktübersicht

Produkteigenschaften

Bilder